posted on 2017-08-23, 14:34authored byNeil J. Oldfield, Caroline Cayrou, Mahab A. K. AlJannat, Ali A. A. Al-Rubaiawi, Luke R. Green, Shehzan Dada, Oliver D. Steels, Christopher Stirrup, Joe Wanford, Banan A. Y. Atwah, Christopher D. Bayliss, David P. J. Turner
MenACWY conjugate vaccination was recently introduced in the United Kingdom for adolescents and young adults to reduce disease from infection by Neisseria meningitidis group W. We conducted a cross-sectional meningococcal carriage study in first-year UK university students. Despite 71% MenACWY vaccine coverage, carriage of group W increased substantially.
History
Citation
Emerging Infectious Disease, 2017, 23 (6), pp. 1009-1011
Author affiliation
/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/MBSP Non-Medical Departments/Department of Genetics